HOME Top Market Reports Indian Peptides and Heparin Market by Type (Insulin, Teriparatide, Liraglutide, Leuprolide, Leuprolide, Exenatide, Calcitonin, Enaxaparin Sodium, Heparin Sodium), Application (Diabetes, Infectious Diseases, Cancer, Osteoporosis) - Forecast to 2022

Indian Peptides and Heparin Market by Type (Insulin, Teriparatide, Liraglutide, Leuprolide, Leuprolide, Exenatide, Calcitonin, Enaxaparin Sodium, Heparin Sodium), Application (Diabetes, Infectious Diseases, Cancer, Osteoporosis) - Forecast to 2022

By: marketsandmarkets.com
Publishing Date: August 2017
Report Code: PH 5511

 

  Speak to Analyst Enquiry Before Buying Webinar
purchase report
download pdf  request for customisation


Indian Peptides Market

The Indian peptides market is expected to reach USD 883.0 Million in 2022 from USD 381.8 Million in 2016 and is expected to register a CAGR of 15.0%. Factors such as increasing prevalence of chronic diseases, rising aging population, and increasing healthcare expenditure are contributing to the growth of this market.

Indian Heparin Market

The Indian heparin market is expected to reach USD 170.2 Million in 2022 from USD 127.8 Million in 2016 and is expected to register a CAGR of 4.9%. Factors such as incidence of coagulation disorders and government support for pharmaceutical companies are contributing to the growth of this market.

Years considered in this report

2016 – Base Year
2017 – Estimated Year
2022 – Projected Year

The objectives of this study are as follows:

  • To define, describe, and forecast the Indian peptides and heparin market on the basis of type and application
  • To provide detailed information regarding the major factors influencing growth of the market (drivers, restraints, opportunities, and challenges)
  • To analyze the opportunities in the market for stakeholders and provide details of a competitive landscape for market leaders
  • To profile key players and comprehensively analyze their market shares and core competencies in terms of market development and growth strategies

Research Methodology

Top-down and bottom-up approaches were used to estimate and validate the size of the Indian peptides and heparin market and to estimate the size of various other dependent submarkets. The overall market size was used in the top-down approach to estimate the sizes of other individual markets (mentioned in the market segmentation by type and application) through percentage splits from secondary and primary research. The bottom-up approach was also implemented (wherever applicable) for data extracted from secondary research to validate the market segment revenues obtained. Various secondary sources referred to for this research study include publications from government sources such as the Indian Peptide Society (IPS), World Health Organization (WHO), GLOBOCAN, Canadian Institute for Health Information, and India Brand Equity Foundation (IBEF), Indian Council of Medical Research (ICMR), International Osteoporosis Foundation (IOF), Central Drugs Standard Control Organization, Indian Society for Study of Pain (ISSP), The Association of Physicians of India; corporate filings such as annual reports, investor presentations, and financial statements have been used to identify and collect information useful for this extensive commercial study of the Indian peptides and heparin market. Primary sources such as experts from related industries and suppliers have been interviewed to obtain and verify critical information as well as to assess prospects of the Indian peptides and heparin market. The breakdown of primaries is shown in the figure below:

The Indian Peptides and Heparin Market

To know about the assumptions considered for the study, download the pdf brochure

Key players in the Indian peptides market

Key players operating in the Indian peptides market include Abbott Laboratories (U.S.), Sanofi S.A. (France), Eli Lilly and Company (U.S.), Cipla Limited (India), and Biocon Limited (India), Intas Pharmaceuticals Ltd. (India), Sun Pharmaceutical Industries Ltd. (India), Cadila Pharmaceuticals (India), Lupin Limited (India), Emcure Pharmaceuticals Ltd. (India), Novartis International AG (Switzerland), Dr. Reddy’s Laboratories Limited (India), and Alkem Laboratories Limited (India)

Key players in the Indian heparin market

Key players operating in the Indian heparin market include Sanofi (France), Emcure Pharmaceutical Pvt. Ltd. (India), Cipla Ltd. (India), Bharat Serum (India), Pfizer Inc. (U.S.), Abbott Laboratories (U.S.), and Lupin Ltd. (India), Dr. Reddy’s Laboratories (India), Intas Pharmaceuticals Ltd. (India), Samarth Life Sciences (India), Claris Lifesciences Limited (India), Gland Pharma Limited (India), Mylan Pharmaceutical (India), Torrent Pharmaceuticals (India), and Micro Labs Ltd. (India).

Target Audience for this Report:

  • Peptide and heparin molecules manufacturers
  • Peptide and heparin molecules marketing players
  • Peptide and heparin molecules distributors
  • Various research and consulting companies

Value Addition for the Buyer:

This report aims to provide insights into the Indian peptides and heparin market. It provides valuable information on peptides, by type and application and heparin, by type. Detailed information of peptides and heparin manufacturers and marketing players are also available in this report. In addition, leading players in the market are profiled to understand the strategies undertaken by them to be competitive in this market.

Scope of the Indian Peptides and Heparin Market Report:

This report categorizes the Indian peptides and heparin market into the following segments:

  1. Indian Peptides Market, By Type
    • Insulin
    • Teriparatide
    • Liraglutide
    • Octreotide Acetate
    • Calcitonin-Salmon
    • Triptorelin
    • Eptifibatide
    • Glatiramer Acetate
    • Bivalirudin
    • Glucagon
    • Exenatide
    • Other Molecules
  2. Indian Peptides Market, By Application
    • Diabetes
    • Infectious Diseases
    • Cancer
    • Osteoporosis
    • Cardiology
    • Gynecology
    • Other Applications
  3. Indian Heparin Market, By Type
    • Enoxaparin Sodium
    • Heparin Sodium
    • Fondaparinux
    • Dalteparin Sodium

Customization Options:

  • Detailed analysis and profiling of additional market players (up to 5)

Table of Contents

1 Indian Peptides Market Overview (Page No. - 11)
    1.1 Introduction
    1.2 Indian Peptides Market Dynamics
           1.2.1 Drivers
                    1.2.1.1 Rising Incidence of Diseases
                    1.2.1.2 Favorable Government Initiatives for the Pharmaceutical Sector
           1.2.2 Restraint
                    1.2.2.1 Availability of Alternative Drugs
           1.2.3 Opportunity
                    1.2.3.1 Patent Expiry of Blockbuster Peptides
           1.2.4 Challenge
                    1.2.4.1 Regulatory and Pricing Issues

2 Indian Peptides Market, By Type (Page No. - 16)
    2.1 Introduction
    2.2 Insulin
           2.2.1 Insulin Market : Companies With Pipeline Product
    2.3 Teriparatide
           2.3.1 Teriparatide Acetate Market: Companies With Pipeline Products
    2.4 Liraglutide
    2.5 Leuprolide Acetate
           2.5.1 Leuprolide Acetate Market: Companies With Pipeline Products
    2.6 Octreotide Acetate
    2.7 Calcitonin-Salmon
    2.8 Triptorelin
    2.9 Eptifibatide
    2.10 Glatiramer Acetate
    2.11 Bivalirudin
    2.12 Glucagon
    2.13 Exenatide
           2.13.1 Exenatide Market: Companeis With Pipeline Products
    2.14 Other Molecules

3 Indian Peptides Market, By Application (Page No. - 32)
    3.1 Introduction
    3.2 Diabetes
    3.3 Infectious Diseases
    3.4 Cancer
    3.5 Osteoporosis
    3.6 Cardiology
    3.7 Gynecology
    3.8 Other Applications

4 Indian Peptides Market Share Analysis (Page No. - 36)

5 Indian Peptides Market Company Profiles (Page No. - 37)
(Business Overview, Products Offered)*
    5.1 Biocon Limited
    5.2 Sun Pharmaceutical Industries Ltd.
    5.3 Wockhardt Ltd.
    5.4 Intas Pharmaceuticals Ltd.
    5.5 Cipla Limited
    5.6 Emcure Pharmaceuticals Pvt. Ltd.
    5.7 Zydus Cadila
    5.8 Bharat Serum and Vaccines Limited
    5.9 Natco Pharma Limited
    5.10 Dr. Reddy's Laboratories

*Details on Marketsandmarkets View, Business Overview, Products Offered Might Not Be Captured in Case of Unlisted Companies.

6 Indian Heparin Market Overview (Page No. - 53)
    6.1 Introduction
    6.2 Indian Heparin Market Dynamics
           6.2.1 Drivers
                    6.2.1.1 Growing Incidence of Coagulation Disorders
                    6.2.1.2 Government Support for the Pharmaceutical Industry
           6.2.2 Restraint
                    6.2.2.1 High Degree of Consolidation to Hinder Small Players From Entering the Market
           6.2.3 Challenge
                    6.2.3.1 Regulatory and Pricing Issues

7 Indian Heparin Market, By Type (Page No. - 57)
    7.1 Introduction
    7.2 Enoxaparin Sodium
           7.2.1 Enoxaparin Sodium Market: Companies With Pipeline Products
    7.3 Heparin Sodium
    7.4 Fondaparinux
           7.4.1 Fondaparinux Market: Companies With Pipeline Products
    7.5 Dalteparin Sodium
           7.5.1 Dalteparin Sodium Market: Companies With Pipeline Products

8 Indian Heparin Market Share Analysis (Page No. - 63)

9 Indian Heparin Market Company Profiles (Page No. - 64)
(Business Overview, Products Offered)*
    9.1 Cipla Ltd.
    9.2 Emcure Pharmaceuticals Pvt. Ltd.
    9.3 Gland Pharma Limited
    9.4 Troikaa Pharmaceuticals Ltd.
    9.5 Biological E Limited
    9.6 Bharat Biotech
    9.7 Samarth Life Sciences Pvt. Ltd.
    9.8 VHB Life Sciences Limited
    9.9 Celon Laboratories Pvt. Ltd.
    9.10 United Biotech (P) Limited
*Details on Marketsandmarkets View, Business Overview, Products Offered Might Not Be Captured in Case of Unlisted Companies.
    9.11 Author Details


List of Tables (45 Tables)

Table 1 Incidence of Cancer Cases in India, 2015 vs 2025
Table 2 Peptides and Their Alternatives
Table 3 Indian Peptides Market, By Type, 2016–2022 (USD Million)
Table 4 Insulin Market: Manufacturers and Brands
Table 5 Insulin Market: Key Players and Brands
Table 6 Teriparatide Acetate Market: Manufacturers and Brands
Table 7 Teriparatide Acetate Market: Key Players and Brands
Table 8 Liraglutide Market: Key Players and Brands
Table 9 Leuprolide Acetate Market: Manufacturers and Brands
Table 10 Leuprolide Acetate Market: Key Players and Brands
Table 11 Octreotide Acetate Market: Manufacturers and Brands
Table 12 Octreotide Acetate Market: Key Players and Brands
Table 13 Calcitonin-Salmon Market: Manufacturers and Brands
Table 14 Calcitonin-Salmon Market: Key Players and Brands
Table 15 Triptorelin Market: Manufacturers and Brands
Table 16 Triptorelin Market: Key Players and Brands
Table 17 Eptifibatide Market: Manufacturers and Brands
Table 18 Eptifibatide Market: Key Players and Brands
Table 19 Glatiramer Acetate Market: Manufacturers and Brands
Table 20 Glatiramer Acetate Market: Key Players and Brands
Table 21 Bivalirudin Market: Manufacturers and Brands
Table 22 Bivalirudin Market: Key Players and Brands
Table 23 Glucagon Market: Key Players and Brands
Table 24 Exenatide Market: Key Players and Brands
Table 25 Colistin Molecule: Manufactureres and Brands
Table 26 Colistin Market: Key Players and Brands
Table 27 Enalapril Molecule: Manufactureres and Brands
Table 28 Enalapril Market: Key Players and Brands
Table 29 Caspofungin: Manufactureres and Brands
Table 30 Caspofungin Market: Key Players and Brands
Table 31 Bortezomib: Manufactureres and Brands
Table 32 Bortezomib Market: Key Players and Brands
Table 33 Oxytocin: Manufacturers and Brands
Table 34 Oxytocin Market: Key Players and Brands
Table 35 Indian Peptides Market Size, By Application, 2016–2022 (USD Million)
Table 36 Incidence of Cancer Cases in India, 2015 vs 2025
Table 37 Indian Heparin Market, By Type, 2016–2022 (USD Million)
Table 38 Enoxaparin Sodium Market: Manufacturers and Brands
Table 39 Enoxaparin Sodium Market: Key Players and Brands
Table 40 Heparin Sodium Market: Manufacturers and Brands
Table 41 Heparin Sodium Market: Key Players and Brands
Table 42 Fondaparinux Market: Manufacturers and Brands
Table 43 Fondaparinux Market: Key Players and Brands
Table 44 Dalteparin Sodium Market: Manufacturers and Brands
Table 45 Dalteparin Sodium Market: Key Players and Brands


List of Figures (15 Figures)

Figure 1 Indian Peptides Market: Drivers, Restraints, Opportunities, and Challenges
Figure 2 Drug Approvals in India
Figure 3 Other Molecules: Market Share, 2016
Figure 4 Indian Peptides Market Share, By Key Player, 2016
Figure 5 Company Snapshot: Biocon Limited (2016)
Figure 6 Company Snapshot: Sun Pharmaceutical Industries Ltd (2016)
Figure 7 Company Snapshot: Wockhardt Ltd. (2016)
Figure 8 Company Snapshot: Intas Pharmaceuticals Ltd (2016)
Figure 9 Company Snapshot: Cipla Limited(2016)
Figure 10 Company Snapshot: Zydus Cadila (2016)
Figure 11 Company Snapshot: Natco Pharma Limited (2016)
Figure 12 Company Snapshot: Dr. Reddy’s Laboratories (2016)
Figure 13 Indian Heparin Market: Drivers, Restraints, and Challenges
Figure 14 Indian Heparin Market Share, By Key Player, 2016
Figure 15 Company Sanpshot: Cipla Ltd.

The Indian peptides market is expected to reach USD 883.0 Million by 2022 from USD 381.8 Million in 2016, at a CAGR of 15.0%. Increasing prevalence of chronic diseases such as diabetes, cancer, and osteoporosis and favorable government policies for the pharmaceutical sector are expected to drive the growth of this market.

The Indian peptides market is segmented by type and application. By type, the Indian peptides market is segmented into calcitonin-salmon, glucagon, insulin, leuprolide acetate, octreotide acetate, teriparatide, exenatide, bivalirudin, glatiramer acetate, eptifibatide, triptorelin, liraglutide, and other molecules. Insulin segment dominated the Indian peptides market in 2016. The growing incidence of diabetes in India are the key factors driving the growth of this segment.

On the basis of application, the Indian peptides market segmented into diabetes, cancer, cardiovascular disease (CVD), gynecological application, infectious diseases, osteoporosis, and other applications (acromegaly, multiple sclerosis, and hepatitis). Diabetes segment accounts for the largest segment and is also the fastest growing application segment in the market. The increasing prevalence and incidence of diabetes and rising awareness about the benefits of early diagnosis are the major factors driving the growth of this market.

Biocon Limited, Sun Pharmaceutical Industries Limited, Wokhardt Limited, Intas Pharmaceutical Limited, Cipla Limited, Emcure Pharmaceutical Limited, and Zydus Cadila have been identified as the top players in this market. These companies have a broad product portfolio with comprehensive features. These companies have products for all end users in this segment, a strong geographical presence, and more importantly, focus on continuous product innovations.

The Indian heparin market is expected to reach USD 170.2 million by 2022 from USD 127.8 million in 2016, at a CAGR of 4.9%. The growing incidence of coagulation disorders and government support for pharmaceutical companies are expected to drive the growth of this market.

The Indian heparin market is segmented by type. By type, the Indian heparin market is segmented into heparin sodium, enoxaparin sodium, fondaparinux, and dalteparin sodium. The enoxaparin sodium segment dominated the Indian peptides market in 2016. The growing incidence of coagulation disorder in India are the key factors driving the growth of this segment.

The Indian Peptides and Heparin Market

Availability of alternative drugs and the high degree of market consolidation are restraining the growth of the Indian peptides and heparin market. For example, the top players in this market are large & well established and enjoy a high degree of brand loyalty.

Emcure Pharmaceutical Pvt. Ltd., Cipla Ltd., Gland Pharma Limited, Troikaa Pharmaceuticals Ltd., and Biological E Limited have been identified as the top players in this market. These companies have a broad product portfolio with comprehensive features. These companies have products for all end users in this segment, a strong geographical presence, and more importantly, focus on continuous product innovations.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit https://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



Access reports on all high
growth Pharmaceuticals Markets on KnowledgeStore
Request Demo